It can be difficult for Canadians to determine if an internet store is located in Canada, as some sites may appear to be operating in Canada, when in fact they are not. For example, internet stores may have Canada in their name or include a symbol such as a maple leaf that could lead one to assume it is a site operating within Canada. Avoid buying health products from questionable websites. If you have questions about whether an Internet pharmacy is legitimate, contact the licensing body in your province or territory.
The Act provides Health Canada with the authority to seize and detain any health product that is believed to be in contravention of the Act or its Regulations. Health Canada also has the authority to order unlawful imported goods to be removed from Canada, or where removal is not possible, order the goods to be destroyed.
Note: Under section 30.7 (1) of the Act, Health Canada may recover expenses associated with the storage, transport or disposal of seized goods or the removal or destruction of unlawfully imported goods from the owner or importer or the person having possession, care or control of it at the time of the inspection. Furthermore, Health Canada is not responsible for any consequences including financial loss as a result of an admissibility determination made in accordance with its authority under the Act.
Health products are generally associated with the treatment or diagnosis of a disease, sickness or human/animal condition. They are separate from cosmetics which are regulated under the Act, but not as a drug or a medical device. Cosmetics do not have a therapeutic purpose and are typically used for cleansing, improving or altering the complexion of the skin, hair or teeth, including, deodorants and perfumes. The addition of health claims can make a product that would otherwise appear to be a cosmetic, a health product. The following types of health products are regulated under the Act and its associated Regulations in Canada:
If the health product does not include directions for use or if the directions for use are in a foreign language or unclear, Health Canada may look at dosage instructions from similar products or recognized sources.
Some health products, particularly prescription drugs, may also contain controlled substances. A health product that is a controlled drug or substance in Canada has its own regulations and rules, including specific import requirements. You are responsible for making sure you meet any rules or conditions that apply to your situation. Find more information on travelling to or from Canada with prescription medications that contain controlled substances.
Health Canada recognizes the need for continued treatment without interruption of medical conditions that began outside of Canada. If you are a Canadian resident under the long-term care of a doctor from another country, you should contact a Canadian medical practitioner to get the medication within Canada.
2 Devesa, J., Almengló, C., & Devesa, P. (2016, October 12). Multiple effects of growth hormone in the body: Is it really the hormone for growth? Clinical medicine insights. Endocrinology and diabetes. Retrieved October 4, 2021, from
3 Lu, M., Flanagan, J. U., Langley, R. J., Hay, M. P., & Perry, J. K. (2019, February 8). Targeting growth hormone function: Strategies and therapeutic applications. Nature News. Retrieved October 4, 2021, from -019-0036-y.
Recombinant bovine growth hormone (rBGH) or recombinant bovine somatotropin (rBST) refers to bovine growth hormone that is made in a lab using genetic technology. Some rBGH products on the market differ chemically from a cow's natural somatotropin by one amino acid. Both the natural and recombinant forms of the hormone stimulate a cow's milk production by increasing levels of another hormone known as insulin-like growth factor (IGF-1).
First, does drinking milk from rBGH-treated cows increase blood levels of growth hormone or IGF-1 in consumers? If it does, would this be expected to have any health effects in people, including increasing the risk of cancer? Several scientific reviews have looked at these issues and are the main focus of this document.
Bovine growth hormone levels are not significantly higher in milk from rBGH-treated cows. On top of this, BGH is not active in humans, so even if it were absorbed from drinking milk, it wouldn't be expected to cause health effects.
Of greater concern is the fact that milk from rBGH-treated cows has higher levels of IGF-1, a hormone that normally helps some types of cells to grow. Several studies have found that IGF-1 levels at the high end of the normal range may influence the development of certain tumors. Some early studies found a relationship between blood levels of IGF-1 and the development of prostate, breast, colorectal, and other cancers, but later studies have failed to confirm these reports or have found weaker relationships. While there may be a link between IGF-1 blood levels and cancer, the exact nature of this link remains unclear.
Although the use of rBGH is still approved in the United States, demand for the product has decreased in recent years. Many large grocery store chains no longer carry milk from cows treated with rBGH. A United States Department of Agriculture survey conducted in 2007 found that less than 1 in 5 cows (17%) were being injected with rBGH.
Allen NE, Key TJ, Appleby PN, et al. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 2007;16:1121-1127.
Traveling to Cleveland Clinic Canada Midtown?Due to ongoing city construction in the Yonge & Eglinton area, please give yourself extra time for travel to and from the clinic.Parking at Cleveland Clinic Canada Midtown
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
CJD is a rare, progressive and fatal brain disorder that occurs in all parts of the world and has been known about for decades. CJD is different from variant CJD, the disease in humans thought to be associated with Mad Cow disease in the United Kingdom and elsewhere. There is no longer a deferral for travel, residence or transfusion in the United Kingdom, Ireland, and France from 1980 to present, which was previously considered a geographic risk of possible exposure to vCJD. Individuals who have been previously deferred for travel, residence or transfusion in the United Kingdom, Ireland and France can initiate donor reinstatement by contacting the Red Cross Donor and Client Support Center at 1-866-236-3276. Individuals with questions about their donation eligibility can contact the Red Cross Donor and Client Support Center at 1-866-236-3276.
There is evidence that CJD can be transmitted from donors to patients through blood transfusions. There is no test for CJD that could be used to screen blood donors. This means that blood programs must take special precautions to keep CJD out of the blood supply by not taking blood donations from those who might have acquired this infection.
You are considered to be at higher risk of carrying CJD if you received a dura mater (brain covering) graft. If you have had a dura mater transplant, you cannot donate blood until more is known about CJD and the risk to the blood supply. If you have been diagnosed with vCJD, CJD or any other TSE or have a blood relative diagnosed with genetic CJD (e.g., fCJD, GSS, or FFI) you cannot donate. If you received an injection of cadaveric pituitary human growth hormone (hGH) you cannot donate. Human cadaveric pituitary-derived hGH was available in the U.S. from 1958 to 1985. Growth hormone received after 1985 is acceptable.
Hepatitis caused by Hepatitis B virus and Hepatitis C virus can be easily transmitted from donors to patients through transfusion. It is possible for a donor to carry a hepatitis virus even though he has never been sick with an inflamed liver, and he feels entirely well at the time of donation.
Hepatitis B and hepatitis C are transmitted between people through sexual contact and blood-to-blood contact, such as occurs when needles are shared during IV drug use. Hepatitis viruses can also be transmitted from mothers to their unborn babies. However, many people who have hepatitis virus infection cannot determine how they became infected. There is a vaccine for the hepatitis A and B viruses.
Malaria is a blood infection caused by a parasite that can be transmitted from a donor to a patient through transfusion. It is possible to have a new infection with malaria but have no symptoms, even though the parasite is present in your blood. It is also possible to feel well, but have a very mild case of malaria, especially if you have lived for extended periods of time in parts of the world where malaria is found.
The Centers for Disease Control and Prevention keep track of the locations with malaria for international travelers from the United States, and this information is available on their web site. You can see if malaria is found in the location you traveled to or lived in by searching for it on the CDC web- site. Malaria Information by country can be found at _table/a.html.
Blood donations are not tested for malaria. Therefore, it is important that people who may have malaria or been exposed to malaria because of living in, or traveling to, a country where malaria is present not be allowed to donate blood until enough time has passed to be certain that they are not infected with malaria. This is done by having a waiting period for those who lived in, move from, or traveled to, the locations with malaria. 781b155fdc